In an elegant and insightful study in this issue, Pan and colleagues8 investigated how glucocorticoid receptor activation contributes to platinum resistance in human cancers and used a series of preclinical studies and analyses of platinum-treated patient tumor specimens. The gene discussed is NR3C1; the disease is neoplasm.